Coral Laboratories Faces ₹2.05 Lakh Payment Dispute Under MSMED Act
Coral Laboratories Ltd announced it received a notice from the MSEFC in Surat under the Micro, Small, and Medium Enterprises Development (MSMED) Act, 2006. The notice relates to an alleged payment default of ₹2.05 Lakhs owed to petitioner M/s Power Cool Service.
Company's Stance and Financial Impact
The company is currently reviewing the matter and believes the claims are not tenable. Coral Laboratories plans to contest the notice through appropriate legal channels. The financial impact of this dispute is yet to be ascertained.
Context of the MSMED Act
The MSMED Act, 2006, was established to ensure timely payments to micro and small enterprises. It facilitates dispute resolution through councils like the MSEFC. Although the current claim is for a modest amount, contesting it will require management's attention and may incur legal costs.
Company Background
Coral Laboratories is a pharmaceutical manufacturer with domestic and export operations. In December 2024, the company faced a ₹45,000 penalty from the BSE for a delayed submission of its Limited Review Report.
